Operating Segments (Tables)

12 Months Ended

Dec. 31, 2023

Operating Segments

Schedule of operating segments

	For the Years Ended
	December 31,
	2023		2022
Revenues
Specialized BioTherapeutics	$	395,124	$	31,929
Public Health Solutions		444,235		916,982
Total	$	839,359	$	948,911
Income (loss) from Operations
Specialized BioTherapeutics	$	(2,812,303)	$	(7,614,988)
Public Health Solutions		(36,531)		26,612
Corporate		(4,849,106)		(6,650,528)
Total	$	(7,697,940)	$	(14,238,904)
Amortization and Depreciation Expense
Specialized BioTherapeutics	$	3,932	$	10,087
Public Health Solutions		655		1,681
Corporate		1,967		12,794
Total	$	6,554	$	24,562
Other (Expense) Income, Net
Specialized BioTherapeutics	$	25,267	$	102,320
Corporate		(235,860)		(816,690)
Total	$	(210,593)	$	(714,370)
Share-Based Compensation
Specialized BioTherapeutics	$	145,683	$	138,075
Public Health Solutions		4,782		4,804
Corporate		219,717		190,510
Total	$	370,182	$	333,389

	As of December 31,
	2023		2022
Identifiable Assets
Specialized BioTherapeutics	$	272,099	$	103,742
Public Health Solutions		3,976		121,290
Corporate		9,521,251		14,054,685
Total	$	9,797,326	$	14,279,717